Tower Wealth Partners Inc. Increases Position in UnitedHealth Group Incorporated (NYSE:UNH)

Tower Wealth Partners Inc. boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 1,099 shares of the healthcare conglomerate’s stock after buying an additional 62 shares during the period. Tower Wealth Partners Inc.’s holdings in UnitedHealth Group were worth $556,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in the business. NewSquare Capital LLC purchased a new position in shares of UnitedHealth Group in the fourth quarter worth $25,000. AlphaMark Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. Promus Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $32,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group during the third quarter valued at approximately $37,000. Finally, Pillar Financial Advisors LLC bought a new stake in UnitedHealth Group in the 4th quarter worth approximately $40,000. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the firm’s stock in a transaction on Friday, January 17th. The stock was acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Up 1.2 %

UNH opened at $493.35 on Monday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The stock has a fifty day moving average price of $513.78 and a 200-day moving average price of $553.39. The firm has a market cap of $451.28 billion, a price-to-earnings ratio of 31.83, a PEG ratio of 1.37 and a beta of 0.62. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The firm had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 EPS. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be paid a dividend of $2.10 per share. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 1.70%. UnitedHealth Group’s payout ratio is 54.19%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on UNH shares. KeyCorp reaffirmed an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Barclays cut their price objective on shares of UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a research report on Friday, January 17th. Wells Fargo & Company dropped their price target on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft boosted their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Finally, Oppenheimer raised their price target on UnitedHealth Group from $610.00 to $640.00 and gave the stock an “outperform” rating in a research note on Friday, December 6th. One investment analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.